Whitehawk Therapeutics
WHWK
21 hedge funds and large institutions have $11.7M invested in Whitehawk Therapeutics in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.
905% more capital inflows, than outflows
Capital inflows: $1.57M | Capital outflows: $157K
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
17% more funds holding
Funds holding: 18 → 21 (+3)
3.97% more ownership
Funds ownership: 19.08% → 23.06% (+4%)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.19M |
| 2 |
Johnson Investment Counsel
Cincinnati,
Ohio
|
+$280K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$29.2K |
| 4 |
Goldman Sachs
New York
|
+$25.6K |
| 5 |
Two Sigma Securities
New York
|
+$21.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$54K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$36.2K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
-$22.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$14.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$9K |
WHWK Hedge Fund Activity: Q2 2020 in Review
21 of the 4,890 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q2 2020, worth a combined $11.7M — up 175% from $4.26M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new WHWK positions and 3 closed out — a net gain of 3 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.19M. The largest seller was BlackRock, cutting an estimated $54K.
- 21 institutional investors held Whitehawk Therapeutics (WHWK) as of Q2 2020, up from 18 in Q1 2020.
- Funds reported $11.7M of Whitehawk Therapeutics stock for Q2 2020, up 175% quarter-over-quarter.
- 6 funds opened new Whitehawk Therapeutics positions in Q2 2020 and 3 closed out, a net change of +3 holders.
- The largest Whitehawk Therapeutics buyer in Q2 2020 was Renaissance Technologies, an estimated $1.19M added.
- The largest Whitehawk Therapeutics seller in Q2 2020 was BlackRock, an estimated $54K sold.
Based on aggregated 13F filings for Q2 2020.